The Helios Scholars program at TGen is having its 10th anniversary. The program, sponsored by Arizona's Helios Education Foundation, helps educate a new generation of scientists, researchers and physicians in Arizona’s bioscience sector. We’ll discuss the program and the results it’s produced with Dr. Jeffrey Trent, president and Research Director of TGen, Paul Luna, president and CEO of the Helios Education Foundation and Carly Benford, a 2010 alumna of Helios Scholars at TGen.
A Stand Up to Cancer (SU2C) Melanoma Dream Team, led by TGen President Dr. Jeffrey Trent of Phoenix, is launching a set of nationwide clinical trials on a form of melanoma skin cancer that affects about half of all people who get the disease. Mayo Clinic in Arizona is the only clinical trial location in our state. Dr. Trent and Dr. Alex Sekulic of Mayo Clinic will discuss the melanoma clinical trials.
The Phoenix-based Translational Genomics Research Institute (TGen) is partnering with the Van Andel Research Institute in Michigan to study cancers in dogs. The goal is to find ways to improve the health of both dogs and people. President and Research Director for TGen Dr. Jeffrey Trent talks about the research project.
Dr. Jeffrey Trent, President and Research Director of TGEN; Marty Shultz, Chair of the Arizona Bioscience Roadmap Steering Committee; and Dr. Michael Mobley of ASU's Biodesign Institute and Board Chairman of the Arizona Bioindustry Association discuss what Arizona is doing to grow its biotech sector and become a global leader in bioscience research and commerce.